P

Inventor

WHITLOCK Gavin

GB11 patents
⚠️ This page may combine multiple inventors who share the name “WHITLOCK Gavin”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MISSION THERAPEUTICS LTD

5 patents
US10689345B2Jun 23, 2020

1-cyano-pyrrolidine compounds as USP30 inhibitors

MISSION THERAPEUTICS LTD4 citations81
US10343992B2Jul 9, 2019

1-cyano-pyrrolidine compounds as USP30 inhibitors

MISSION THERAPEUTICS LTD7 citations81
US11390584B2Jul 19, 2022

1-cyano-pyrrolidine compounds as USP30 inhibitors

MISSION THERAPEUTICS LTD1 citations70
US11066365B2Jul 20, 2021

1-cyano-pyrrolidine compounds as USP30 inhibitors

MISSION THERAPEUTICS LTD0 citations60
US11053198B2Jul 6, 2021

1-cyano-pyrrolidine compounds as USP30 inhibitors

MISSION THERAPEUTICS LTD0 citations60

MUNA THERAPEUTICS APS

2 patents
US12459953B2Nov 4, 2025

TREM2 modulators

MUNA THERAPEUTICS APS0 citations55
US12459952B2Nov 4, 2025

TREM2 modulators

MUNA THERAPEUTICS APS0 citations55

ACCENT THERAPEUTICS INC

2 patents
US12233065B2Feb 25, 2025

Inhibitors of RNA helicase DHX9 and uses thereof

ACCENT THERAPEUTICS INC0 citations55
US12162867B2Dec 10, 2024

Inhibitors of RNA helicase DHX9 and uses thereof

ACCENT THERAPEUTICS INC0 citations55

IP2IPO INNOVATIONS LTD

1 patent
US11945799B2Apr 2, 2024

4-ethynylpyridine derivatives useful as GCN2 inhibitors

IP2IPO INNOVATIONS LTD0 citations60

PFIZER

1 patent
US7928099B2Apr 19, 2011

Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists

PFIZER1 citations45